Terms: = Bone cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814
17 results:
1. A Young Patient with Undiagnosed Polycythemia-Paraganglioma Syndrome: A Case Report.
Alaklabi AM; Arabi TZ; Bin Saeedan MN; Alotaibi GS
Am J Case Rep; 2023 May; 24():e938676. PubMed ID: 37160900
[TBL] [Abstract] [Full Text] [Related]
2. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
[TBL] [Abstract] [Full Text] [Related]
3. Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features.
Thompson AS; Giri N; Gianferante DM; Jones K; Savage SA; Alter BP; McReynolds LJ
Pediatr Res; 2022 Dec; 92(6):1671-1680. PubMed ID: 35322185
[TBL] [Abstract] [Full Text] [Related]
4. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
[TBL] [Abstract] [Full Text] [Related]
5. Surgical Treatment of Intraorbital Lesions.
Aftahy AK; Krauss P; Barz M; Wagner A; Meyer B; Negwer C; Gempt J
World Neurosurg; 2021 Nov; 155():e805-e813. PubMed ID: 34509678
[TBL] [Abstract] [Full Text] [Related]
6. C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in hif2a: Clinical Evidence for EPO Regulating FGF23.
Roszko KL; Brown S; Pang Y; Huynh T; Zhuang Z; Pacak K; Collins MT
J Bone Miner Res; 2021 Feb; 36(2):315-321. PubMed ID: 33049075
[TBL] [Abstract] [Full Text] [Related]
7. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression.
Kim H; Cho Y; Kim HS; Kang D; Cheon D; Kim YJ; Chang MJ; Lee KM; Chang CB; Kang SB; Kang HG; Kim JH
Nat Commun; 2020 Oct; 11(1):5023. PubMed ID: 33024108
[TBL] [Abstract] [Full Text] [Related]
8. Deciphering Master Gene Regulators and Associated Networks of Human Mesenchymal Stromal Cells.
Sánchez-Luis E; Joaquín-García A; Campos-Laborie FJ; Sánchez-Guijo F; Rivas JL
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32260546
[TBL] [Abstract] [Full Text] [Related]
9. Diseases of renal function and bone metabolism after treatment for early onset cancer: A registry-based study.
Liuhto N; Grönroos MH; Malila N; Madanat-Harjuoja L; Matomäki J; Lähteenmäki P
Int J Cancer; 2020 Mar; 146(5):1324-1332. PubMed ID: 31523804
[TBL] [Abstract] [Full Text] [Related]
10. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract] [Full Text] [Related]
11. Chiari Malformation Type 1 in
Rosenblum JS; Maggio D; Pang Y; Nazari MA; Gonzales MK; Lechan RM; Smirniotopoulos JG; Zhuang Z; Pacak K; Heiss JD
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185588
[TBL] [Abstract] [Full Text] [Related]
12. GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H; Ahmed I; Aljurf M; Askar M; Auletta JJ; Bhatt V; Bredeson C; Chhabra S; Gadalla S; Gajewski J; Gale RP; Gergis U; Hematti P; Hildebrandt GC; Inamoto Y; Kitko C; Khandelwal P; MacMillan ML; Majhail N; Marks DI; Mehta P; Nishihori T; Olsson RF; Pawarode A; Diaz MA; Prestidge T; Qayed M; Rangarajan H; Ringden O; Saad A; Savani BN; Seo S; Shah A; Shah N; Schultz KR; Solh M; Spitzer T; Szer J; Teshima T; Verdonck LF; Williams KM; Wirk B; Wagner J; Yared JA; Weisdorf DJ
Blood Adv; 2019 May; 3(9):1441-1449. PubMed ID: 31053571
[TBL] [Abstract] [Full Text] [Related]
13. Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.
Kim SW; Fishilevich E; Arango-Argoty G; Lin Y; Liu G; Li Z; Monaghan AP; Nichols M; John B
PLoS One; 2015; 10(3):e0120296. PubMed ID: 25798919
[TBL] [Abstract] [Full Text] [Related]
14. Lower blood calcium associates with unfavorable prognosis and predicts for bone metastasis in NSCLC.
Shen H; Li Y; Liao Y; Zhang T; Liu Q; Du J
PLoS One; 2012; 7(3):e34264. PubMed ID: 22479582
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical study of 34 patients with extranodal NK/T cell lymphoma-nasal type].
Ren X; Jia Q; Xiang G; Zhao Z; Xu K; Du W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(8):361-2. PubMed ID: 17608157
[TBL] [Abstract] [Full Text] [Related]
16. Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?
Rades D; Bajrovic A; Alberti W; Rudat V
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):178-81. PubMed ID: 12504051
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia-inducible factor (HIF1A and hif2a), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos C; Turley H; Talks K; Gatter KC; Harris AL
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1192-202. PubMed ID: 12128120
[TBL] [Abstract] [Full Text] [Related]
